Dapagliflozin improves treatment satisfaction in overweight patients with type 2 diabetes mellitus: a patient reported outcome study (PRO study)

被引：0
|
作者：
Hiroki Nakajima
Sadanori Okada
Takako Mohri
Eiichiro Kanda
Naoyuki Inaba
Yoko Hirasawa
Hiroaki Seino
Hisamoto Kuroda
Toru Hiyoshi
Tetsuji Niiya
Hitoshi Ishii
机构：
[1] Nara Medical University,Department of Diabetology
[2] Tokyo Kyosai Hospital,Department of Nephrology
[3] Tokyo Medical and Dental University,Life Science and Bioethics Research Center
[4] Shizuoka Saiseikai General Hospital,Department of Metabolism & Endocrinology
[5] Plumeria DM Clinic,Department of Internal Medicine
[6] Seino Internal Medicine Clinic,undefined
[7] Green Clinic,undefined
[8] Japanese Red Cross Medical Center,undefined
[9] Matsuyama Shimin Hospital,undefined
来源：
Diabetology & Metabolic Syndrome | / 10卷
关键词：
Type 2 diabetes mellitus; Oral hypoglycemic agent; Sodium glucose cotransporters 2 inhibitors; SGLT2 inhibitors; Dapagliflozin; Treatment satisfaction; Oral Hypoglycemic Agent-Questionnaire; Body weight; Patient reported outcome; Quality of life;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Dapagliflozin improves treatment satisfaction in overweight patients with type 2 diabetes mellitus: a patient reported outcome study (PRO study)
    Nakajima, Hiroki
    Okada, Sadanori
    Mohri, Takako
    Kanda, Eiichiro
    Inaba, Naoyuki
    Hirasawa, Yoko
    Seino, Hiroaki
    Kuroda, Hisamoto
    Hiyoshi, Toru
    Niiya, Tetsuji
    Ishii, Hitoshi
    DIABETOLOGY & METABOLIC SYNDROME, 2018, 10
  • [2] Effects of dapagliflozin on patient reported treatment satisfaction in patients with type 2 diabetes mellitus: results from two double-blind trials
    Medin, J.
    Grandy, S.
    Rohwedder, K.
    Hruba, V.
    Sugg, J.
    Langkilde, A. -M.
    DIABETOLOGIA, 2011, 54 : S346 - S346
  • [3] Effects of Dapagliflozin on Patient Reported Treatment Satisfaction in Patients with Type 2 Diabetes Mellitus-Results from Two Double-Blind Trials
    Medin, Jennie
    Grandy, Susan
    Rohwedder, Katja
    Hruba, Veronica
    Sugg, Jennifer
    Langkilde, Anna Maria
    DIABETES, 2011, 60 : A604 - A604
  • [4] DAPAGLIFLOZIN IMPROVES ARTERIAL STIFFNESS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS
    Fernandez-Alonso, Camilo
    Roffidal, Louise
    Sander, Gary
    Giles, Thomas
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 69 (11) : 2022 - 2022
  • [5] THE SGLT2 INHIBITOR DAPAGLIFLOZIN IMPROVES ERECTILE DYSFUNCTION IN PATIENTS WITH TYPE 2 DIABETES MELLITUS: A PROSPECTIVE STUDY
    Cannarella, Rossella
    Condorelli, Rosita A. Angela
    Leanza, Claudia
    Garofalo, Vincenzo
    Lundy, Scott
    Calogero, Aldo E.
    La Vignera, Sandro
    FERTILITY AND STERILITY, 2023, 120 (04) : E245 - E246
  • [6] Dapagliflozin for the Treatment of Type 2 Diabetes Mellitus
    Aylsworth, Andrew
    Dean, Zachary
    VanNorman, Cody
    Okere, Arinze Nkemdirim
    ANNALS OF PHARMACOTHERAPY, 2014, 48 (09) : 1202 - 1208
  • [7] Dapagliflozin acutely improves kidney function in type 2 diabetes mellitus. The PRECARE study
    Lazzaroni, Elisa
    Lunati, Maria Elena
    Montefusco, Laura
    Pastore, Ida
    Chebat, Enrica
    Cimino, Vincenzo
    Morpurgo, Paola Silvia
    Muratori, Milena
    Plebani, Laura
    Bolla, Andrea
    Rossi, Antonio
    Vallone, Luciana
    Gandolfi, Alessandra
    Tinari, Camilla
    D'Addio, Francesca
    Ben Nasr, Moufida
    Loretelli, Cristian
    Scaranna, Cristiana
    Bellante, Rosalia
    Manfrini, Roberto
    Muratori, Fabrizio
    Franzetti, Ivano
    Orsi, Emanuela
    Gazzaruso, Carmine
    Ghelardi, Renata
    Desenzani, Paolo
    Genovese, Stefano
    Girelli, Angela
    Folli, Franco
    Berra, Cesare
    Fiorina, Paolo
    PHARMACOLOGICAL RESEARCH, 2022, 183
  • [8] Dapagliflozin in patients with type 2 diabetes mellitus
    Filippatos, Theodosios D.
    Liberopoulos, Evangelos N.
    Elisaf, Moses S.
    THERAPEUTIC ADVANCES IN ENDOCRINOLOGY AND METABOLISM, 2015, 6 (01) : 29 - 41
  • [9] THE IMPACT OF ADJUNCT DAPAGLIFLOZIN ON TREATMENT SATISFACTION IN TYPE 1 DIABETES MELLITUS
    Gordon, J.
    Beresford-Hulme, L.
    Bennett, H.
    Tank, A.
    Edmonds, C.
    McEwan, P.
    VALUE IN HEALTH, 2019, 22 : S590 - S590
  • [10] Dapagliflozin for the treatment of type 2 diabetes mellitus - an update
    Nicholson, Martha K.
    Ghazal Asswad, Randa
    Wilding, John P. H.
    EXPERT OPINION ON PHARMACOTHERAPY, 2021, 22 (17) : 2303 - 2310
12345